Why Don’t My Eye Drops Work Anymore? The MGD Connection
- Vaugn Schneider
- 18 minutes ago
- 4 min read
Quick Answer: If your eye drops have stopped working, the most likely reason is
meibomian gland dysfunction (MGD) — clogged or atrophied oil glands in your
eyelids. Drops add water; MGD is an oil problem. Treatments that target the
glands directly (BlephEx, TearCare, OptiLight IPL, and radiofrequency therapy)
are what break the cycle.
You used to need drops once or twice a day. Now you keep a bottle on your desk, one in
your bag, one in your car, and one on the nightstand — and they don’t last like they used to.
You are not imagining it. You are not “getting old.” Your eye drops are losing the war
because they were never built to fight the actual battle.
The most common reason eye drops stop working in adult patients is meibomian gland
dysfunction, or MGD. Roughly 70% of adults over 60 have it, and a meaningful percentage
of patients in their 40s and 50s have it without knowing. Once you understand what MGD
is, the failure of your drops makes perfect sense — and so does the right way out.
What drops can and can’t do
A tear has three layers: a thin mucin layer that anchors it to the eye, a watery middle layer
(which is most of the volume), and a thin oil layer on top. The oil layer is the lid on the pot.
Without it, the watery layer evaporates within seconds.
Artificial tears are essentially water with stabilizers. They re-coat your eye, lubricate it, and
add temporary moisture. What they cannot do is restore the oil layer. Add water to a pot
with no lid and the water boils away just as fast. You can buy an extra bottle, switch brands,
or upgrade to gels — but you are still adding water to a pot with no lid.
Meet MGD — the disease behind the disease
Lining the inner edges of your eyelids — about 25 to 40 glands per lid — are the
meibomian glands. Every time you blink, they release a tiny pulse of oil onto your tear
film. When those glands clog with hardened secretions, get inflamed, or eventually atrophy
from chronic inflammation, the oil layer thins or disappears.
That is MGD.
It is progressive, it is silent for years, and it is the single most common cause of evaporative
dry eye disease — the kind that 86% of dry eye patients have. Drops cannot reach the
glands. Warm compresses help marginally. The glands need direct intervention.
What actually fixes it
Modern dry eye care addresses MGD on a treatment ladder, and the right rung depends on
how far the disease has progressed. At Eyes On The Lake we use four primary in-office
tools:
BlephEx. A doctor-performed lid-margin cleaning. We use a soft, medical-grade
microsponge to remove the bacterial biofilm and crusted debris that block the gland
openings. Often this is the first step. Many patients are surprised at how much better their
drops work after a single BlephEx — because now there is something for the drops to land
on.
TearCare. A smart-thermal device that warms each eyelid to a precise temperature for
about 15 minutes, softening the hardened oils inside the glands. Dr. Schneider then
expresses the glands directly during the same visit. The result: oil flowing again, often
immediately.
OptiLight by Lumenis. The only IPL system FDA-approved for managing dry eye
disease. Pulses of light reduce eyelid inflammation, address Demodex mites (a frequent
driver of stubborn MGD), and stimulate gland function. It is our flagship light-based
treatment, and Milwaukee patients usually do a four-session course over a few months.
Radiofrequency therapy (RF). Gentle, controlled heat delivered around the eyes. RF
complements IPL by liquefying stubborn meibum deeper in the lid tissue and reducing the
chronic inflammation cycle.
How we figure out what you need
A dry eye exam in our Bay View office is built around answering one question: what is
actually broken, and what is the most efficient sequence of treatments to fix it? We image the
meibomian glands (you’ll see your own glands on a screen — most patients have never
seen this before). We measure your tear breakup time, tear osmolarity, and lid-margin
health. We screen for Demodex. We talk through your routine, your contact lens wear, your
screen use, and your hormonal history if relevant. Then we map a plan.
Sometimes the plan is BlephEx + a better drop + lid hygiene. Sometimes it is BlephEx +
TearCare + a four-session OptiLight course. Sometimes it includes RF. Plans typically range
from a single targeted session to a four-session package, with full-face OptiLight protocols
priced higher because they include the aesthetic benefits of facial IPL. Most in-office dry
eye treatments are HSA/FSA eligible — we will help you sort out the math.
You don’t have to keep buying drops that don’t work. There is a real diagnosis, and there is
real treatment. Book your dry eye exam at Eyes On The Lake — 414-293-1180 or
online.
FAQ Schema Block
• Q: How do I know if my drops are failing because of MGD?
A: If you’ve added more drops, switched brands, and they still don’t last as long as they used to, MGD is the most likely cause. A meibography exam confirms it.
• Q: Will warm compresses fix MGD?
A: Compresses help mild MGD. By the time drops have failed, in-office gland-focused treatment (TearCare, OptiLight, RF) is usually needed.
• Q: Is OptiLight the same as cosmetic IPL?
A: No. OptiLight by Lumenis is an FDA-approved IPL system specifically for dry eye disease, with eye-safe protocols. Cosmetic IPL devices are not designed for the periocular area.
• Q: How long does it take to see results?
A: BlephEx and TearCare often produce noticeable comfort within days. OptiLight typically shows clear improvement after the second or third session of a four-session protocol.
• Q: Can I keep using my drops while I’m being treated?
A: Yes. Drops still have a role for symptom comfort. The goal is to need them far less over time.